Find and Pitch Jounalists, Get Your Story Covered

Tags: leadership pharma Research & Development research-development biotech

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - 5 months ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - 5 months ago STAT+: Pharmalittle: Pfizer is leaving the BIO trade group; CVS drug-pricing plan may not lower costs for consumers - 6 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - 6 months ago STAT+: Pharmalittle: Novo Nordisk sees “significantly” more Wegovy in the U.S. next year; U.S. pharma layoffs skyrocket - 7 months ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - 7 months ago STAT+: Pharmalittle: Life sciences deals on track to hit lowest point since 2017; EU regulators order Illumina to divest Grail - 7 months ago
2	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	BioMarin appeases an activist - 5 months ago STAT+: 3 trends to watch in biotech in 2024 - 5 months ago Eli Lilly’s latest $1.4 billion deal might come unglued - 6 months ago Legend Biotech’s deal with Novartis is a reminder that biotech’s bear market has a few haves, and many have-nots - 6 months ago
3	Michael Gibney Pharma Voice	Biopharma’s FTC headache deepens with guideline shifts years in the making - 5 months ago Real Chemistry’s CEO on biopharma’s outlook in 2024 - 6 months ago A biotech tackles drug discovery with transcription factor know-how - 6 months ago The thorniest questions facing pharma, according to a leading bioethicist - 7 months ago How Big Pharma keeps the oncology engines hot with a host of strategies - 7 months ago The PharmaVoice 100: Rare disease warriors - 7 months ago The PharmaVoice 100: Trailblazers - 8 months ago
4	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	What are pharma’s next blockbusters? - 5 months ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - 5 months ago Biohaven wants to muscle in on the Ozempic craze with a competing class of drugs - 6 months ago From the rainforest to Wall Street — Jaguar Health’s big play for revitalization - 7 months ago Has the science of anti-aging caught up with the dream of a longer life? - 7 months ago
5	Fran Gregory Pharmacy Times	Expert Reflects on Trends, US Market of Biosimilars in 2023 - 5 months ago
6	Alexandra Pecci Pharma Voice Leading community for life sciences leaders. Washington, D.C. pharmaceuticalslife sciencescommunity building	5 noteworthy pharma AI investments in 2023 - 5 months ago The fortunes and flops of pharma M&A - 6 months ago Biopharma’s top 5 IPOs of 2023 (so far) - 6 months ago The power of genomics-based healthcare remains largely untapped - 6 months ago 5 of the best paid biopharma CEOs - 6 months ago In a record year for biotech bankruptcy, here are 3 companies that went under - 7 months ago Cidara’s J&J-partnered immunotherapy could target flu and cancer - 7 months ago To close the pediatric innovation gap, this biotech has to think differently - 7 months ago Where have all the unicorns gone? A look at 4 billion-dollar biotechs - 8 months ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 5 months ago FDA chastens pet companies over antibiotics - 5 months ago The biotech news you missed from the weekend - 5 months ago Novartis is building a new radioligand plant in China - 6 months ago XBI biotech index rises, giving investors a shred of hope - 7 months ago
8	SVP and GM Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
9	Oracle Life Sciences Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
10	Seema Verma Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago

Journalists covering biopharma